This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lifeward (LFWD) delivered earnings and revenue surprises of -39.39% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
by Zacks Equity Research
Lifeward launches ReWalk 7 in the United States, offering advanced mobility, greater control and smarter walking for individuals with spinal cord injuries.
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton
by Zacks Equity Research
LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lifeward (LFWD) delivered earnings and revenue surprises of -90% and 3.36%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Informatica Inc. (INFA) Q4 Earnings Beat Estimates
by Zacks Equity Research
Informatica Inc. (INFA) delivered earnings and revenue surprises of 7.89% and 6.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Intrusion (INTZ) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Intrusion Inc. (INTZ) and Lifeward (LFWD) have performed compared to their sector so far this year.
Lifeward (LFWD) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Lifeward (LFWD) delivered earnings and revenue surprises of -66.67% and 26.87%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Consensus Cloud Solutions, Inc. (CCSI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Consensus Cloud Solutions (CCSI) delivered earnings and revenue surprises of 2.34% and 2.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Vertex (VERX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Vertex (VERX) delivered earnings and revenue surprises of 14.29% and 2.96%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics (LFWD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
ReWalk (LFWD) delivered earnings and revenue surprises of 5.66% and 0.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Asensus Surgical (ASXC) delivered earnings and revenue surprises of -40% and 69.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aspira (AWH) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aspira (AWH) delivered earnings and revenue surprises of 12.50% and 6.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare, Inc. (SRTS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of 233.33% and 31.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
OPKO Health (OPK) delivered earnings and revenue surprises of 88.89% and 1.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Idexx Laboratories (IDXX) Lags Q2 Earnings Estimates
by Zacks Equity Research
Idexx (IDXX) delivered earnings and revenue surprises of -14.98% and 0.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sight Sciences (SGHT) delivered earnings and revenue surprises of 19.35% and 0.25%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
ReWalk (LFWD) delivered earnings and revenue surprises of -4.29% and 4.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
ReWalk (LFWD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Stocks Backed by High Efficiency to Strengthen Your Portfolio
by Santanu Roy
Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.
Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Hyperfine (HYPR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: ReWalk Robotics (LFWD) Q1 Earnings Expected to Decline
by Zacks Equity Research
ReWalk (LFWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?
by Moumi Mondal
Lifeward's (LFWD) first-quarter 2024 results are expected to reflect the benefits of several milestone achievements from last year.
Bears are Losing Control Over ReWalk (LFWD), Here's Why It's a 'Buy' Now
by Zacks Equity Research
ReWalk (LFWD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks.com featured highlights Post Holdings, ReWalk Robotics, Deckers Outdoor and Ralph Lauren
by Zacks Equity Research
Post Holdings, ReWalk Robotics, Deckers Outdoor and Ralph Lauren have been highlighted in this Screen of The Week article.
4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
by Santanu Roy
Invest in companies like Post Holdings (POST), ReWalk Robotics Ltd. (LFWD), Deckers Outdoor (DECK) and Ralph Lauren (RL) to make the most of their higher efficiency levels.